Bell Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bell Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,515	Closed	-$4.03M	–	69
2025 Q2	$4.03M	Sell	7,515 -7,208	-49%	-$3.45M	0.89%	49
2025 Q1	$6.18M	Buy	14,723 +3,514	+31%	+$1.53M	1.14%	33
2024 Q4	$4.63M	Buy	+11,209	New	+$4.92M	0.84%	56
2023 Q3	–	Sell	-6,227	Closed	-$3.13M	–	65
2023 Q2	$3.13M	Sell	6,227 -21	-0.3%	-$10.1K	0.54%	62
2023 Q1	$3.12M	Sell	6,248 -1,826	-23%	-$874K	0.57%	60
2022 Q4	$3.29M	Sell	8,074 -1,702	-17%	-$661K	0.62%	60
2022 Q3	$3.19M	Sell	9,776 -129	-1%	-$47.4K	0.65%	57
2022 Q2	$3.47M	Buy	+9,905	New	+$4.04M	0.69%	58
2021 Q1	–	Sell	-6,444	Closed	-$3.22M	–	64
2020 Q4	$3.22M	Sell	6,444 -544	-8%	-$243K	0.7%	60
2020 Q3	$2.75M	Sell	6,988 -1,136	-14%	-$420K	0.68%	60
2020 Q2	$2.68M	Sell	8,124 -7,435	-48%	-$2.15M	0.73%	60
2020 Q1	$3.77M	Buy	+15,559	New	+$4.06M	1.17%	49

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bell Asset Management's IDXX Position: Q3 2025 in Review

Bell Asset Management sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 7,515 shares — an estimated $4.03M sold.

Bell Asset Management first reported a position in IDXX in Q1 2020 and held it in 12 quarters. The position peaked at $6.18M in Q1 2025. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

Bell Asset Management reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
Bell Asset Management sold 7,515 Idexx Laboratories shares in Q3 2025, an estimated $4.03M.
Bell Asset Management first reported a position in Idexx Laboratories in Q1 2020 and held it in 12 quarters.
Bell Asset Management's Idexx Laboratories position peaked at $6.18M in Q1 2025.
1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Bell Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.